SCHEMBL4897358

SCHEMBL4897358

C=CCn1c(-c2ccccc2)c(-c2ccccc2)sc1=NC(=O)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.41
HSD17B10 Q99714 3/20 0.41
KDM4E B2RXH2 9/20 0.40
ALDH1A1 P00352 8/20 0.40
MAPT P10636 7/20 0.40
HPGD P15428 5/20 0.40
SMN1; SMN2 Q16637 5/20 0.40
CNR2 P34972 1/20 0.40
RECQL P46063 1/20 0.40
HTT P42858 2/20 0.39
POLB P06746 1/20 0.38
KMT2A Q03164 2/20 0.38
HRH1 P35367 1/20 0.38
NPC1 O15118 3/20 0.38
MEN1 O00255 1/20 0.38
TP53 P04637 1/20 0.38
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4897354 1.00 RAB9A (0.41) RAB9AHSD17B10KDM4EALDH1A1MAPT
SCHEMBL4614045 0.79 ALDH1A1 (0.41) RAB9AHSD17B10KDM4EALDH1A1MAPT
SCHEMBL4614043 0.79 ALDH1A1 (0.41) RAB9AHSD17B10KDM4EALDH1A1MAPT
SCHEMBL17107239 0.77 RAB9A (0.53) RAB9AHSD17B10KDM4EALDH1A1MAPT
SCHEMBL17131996 0.77 RAB9A (0.53) RAB9AHSD17B10KDM4EALDH1A1MAPT
SCHEMBL17107237 0.77 RAB9A (0.53) RAB9AHSD17B10KDM4EALDH1A1MAPT
SCHEMBL5283752 0.77 ALDH1A1 (0.37) RAB9AHSD17B10KDM4EALDH1A1MAPT
SCHEMBL5283755 0.77 ALDH1A1 (0.37) RAB9AHSD17B10KDM4EALDH1A1MAPT
SCHEMBL13990057 0.76 CNR2 (0.58) RAB9AHSD17B10KDM4EALDH1A1MAPT
SCHEMBL4613599 0.74 ALDH1A1 (0.43) HSD17B10KDM4EALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080312435-A1 Imine Compound TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-18 US disclosed
EP-1820504-A1 IMINE COMPOUND TAISHO PHARMACEUTICAL CO., LTD (JP) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312435-A1 Imine Compound CNR1, CNR2, HRH4 RAB9A 841/4885HSD17B10 1632/4885KDM4E 3386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.